Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Barker

Showing results (631-640 of 649) with videos related to

Pageof 65
Sort By:
Biochemistry|October 16, 2007
Biophysical characterization of an integrin-targeted lipopolyplex gene delivery vectorM Firouz Mohd Mustapa, Paul C Bell, Christopher A Hurley, et al.
Science Advances|September 25, 2024
Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onsetMegan M Hanlon, Conor M Smith, Mary Canavan, et al.
Iscience|July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancerHaineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2026
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcomaAndrew Farrell, Genevieve Dall, Cassandra J Vandenberg, et al.
JAMA Network Open|August 12, 2025
Minimal vs Specialized Exercise Equipment for Pulmonary Rehabilitation: A Randomized Clinical TrialClaire M Nolan, Callum Glen, Jessica A Walsh, et al.
BMC Medical Research Methodology|July 4, 2026
Integrating health economics and implementation science: a call to actionLane Meredith, Helen Skouteris, Sarah Alderson, et al.
Cancers|September 9, 2023
A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature ReviewArwa Abdelmogod, Lia Papadopoulos, Stephen Riordan, et al.
BMC Genomics|November 23, 2005
Efficient gene-driven germ-line point mutagenesis of C57BL/6J miceEdward J Michaud, Cymbeline T Culiat, Mitchell L Klebig, et al.
Therapeutic Advances in Medical Oncology|November 29, 2023
The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft modelsGwo Yaw Ho, Cassandra J Vandenberg, Ratana Lim, et al.
Genomics|January 14, 2024
A risk-reward examination of sample multiplexing reagents for single cell RNA-SeqDaniel V Brown, Casey J A Anttila, Ling Ling, et al.
Pageof 65

Showing results (631-640 of 649) with videos related to

Sort By:
Pageof 65
Biochemistry|October 16, 2007
Biophysical characterization of an integrin-targeted lipopolyplex gene delivery vectorM Firouz Mohd Mustapa, Paul C Bell, Christopher A Hurley, et al.
Science Advances|September 25, 2024
Loss of synovial tissue macrophage homeostasis precedes rheumatoid arthritis clinical onsetMegan M Hanlon, Conor M Smith, Mary Canavan, et al.
Iscience|July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancerHaineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2026
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcomaAndrew Farrell, Genevieve Dall, Cassandra J Vandenberg, et al.
JAMA Network Open|August 12, 2025
Minimal vs Specialized Exercise Equipment for Pulmonary Rehabilitation: A Randomized Clinical TrialClaire M Nolan, Callum Glen, Jessica A Walsh, et al.
BMC Medical Research Methodology|July 4, 2026
Integrating health economics and implementation science: a call to actionLane Meredith, Helen Skouteris, Sarah Alderson, et al.
Cancers|September 9, 2023
A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature ReviewArwa Abdelmogod, Lia Papadopoulos, Stephen Riordan, et al.
BMC Genomics|November 23, 2005
Efficient gene-driven germ-line point mutagenesis of C57BL/6J miceEdward J Michaud, Cymbeline T Culiat, Mitchell L Klebig, et al.
Therapeutic Advances in Medical Oncology|November 29, 2023
The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft modelsGwo Yaw Ho, Cassandra J Vandenberg, Ratana Lim, et al.
Genomics|January 14, 2024
A risk-reward examination of sample multiplexing reagents for single cell RNA-SeqDaniel V Brown, Casey J A Anttila, Ling Ling, et al.
Pageof 65